Shanghai Lunsheng Information Technology Co., Ltd. announced that it expects to receive CNY 8.1 million in funding from Shanghai Haohai Biological Technology Co., Ltd., Shanghai Haoyang Enterprise Management Co., Ltd.
January 20, 2020
Share
Shanghai Lunsheng Information Technology Co., Ltd. announced that it will receive CNY 8,100,000 in an equity round of funding on January 21, 2020. The transaction will include participation from new investor Shanghai Haohai Biological Technology Co., Ltd. (SEHK:6826) for CNY 7,600,000, for a 19% stake in the company and returning investor Shanghai Haoyang Enterprise Management Co., Ltd. for CNY 2,400,000. Post the transaction the registered capital of the company will increase by CNY 2,166,700 to CNY 8,666,700. Post the transaction the shareholding of existing investors Wu Xuejiao will reduce from 57.69% to 43.27%, Shanghai Haoyang Enterprise Management Co., Ltd. will reduce from 30.77% to 29.08% and Shanghai Nadan Enterprise Management Center (General Partnership) will reduce from 11.54% to 8.65%.
Shanghai Haohai Biological Technology Co., Ltd. is a China-based company principally engaged in biological technology-related businesses. The businesses of the Company include the manufacture and sales of biological and medical hyaluronate, the research and development of biological engineering and pharmaceutical products and the provision of related services. Its products include orthopedics products, medical aesthetics and wound care products, ophthalmology products and anti-adhesion and hemostasis products, among others. Orthopedics products include sodium hyaluronate injection, medical chitosan and medical sodium hyaluronate gel. Medical aesthetics and wound care products include recombinant human epidermal growth factor (rhEGF), among others. Ophthalmology products include ophthalmic viscoelastic devices and lubricant eye drops. Anti-adhesion and hemostasis products include medical collagen sponges, among others. The Company mainly operates businesses in Mainland China.
Shanghai Lunsheng Information Technology Co., Ltd. announced that it expects to receive CNY 8.1 million in funding from Shanghai Haohai Biological Technology Co., Ltd., Shanghai Haoyang Enterprise Management Co., Ltd.